As of 9:30 AM on the 15th, Celltrion Healthcare is trading at 106,900 KRW, down 0.19% from the previous day. This represents a 23.73% increase compared to May 28. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.

Over the past five days, individual investors have net sold 110,550 shares, while foreigners and institutions have net bought 630,409 shares and net sold 471,548 shares, respectively.

On June 11, Celltrion Healthcare was a market topic for its "strong position in COVID-19 clinical plans in the UK."

※Source: AI Investment Assistant AI Racciro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing